Aflibercept Versus Bevacizumab as First-Line Therapy in Age-Related Macular Degeneration.

Saved in:

Bibliographic Details
Title:	Aflibercept Versus Bevacizumab as First-Line Therapy in Age-Related Macular Degeneration.
Authors:	SALAVAT, MĂDĂLINA-CASIANA PALFI¹, ȘECLĂMAN, EDWARD PAUL², MUȘAT, ANDREEA-ALEXANDRA³, BORUGĂ, MĂDĂLINA⁴, PATONI, CRISTINA^3,5, POPESCU, MARIUS-NICOLAE^3,6, TEODORESCU, OANA ELENA⁷, MUȘAT, OVIDIU^3,7, PATONI, STELLA IOANA POPESCU^2,7
Source:	Current Health Sciences Journal. Oct-Dec2023, Vol. 49 Issue 4, p503-509. 7p.
Database:	Academic Search Ultimate

Be the first to leave a comment!